If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

Share Price is delayed by 15 minutes
Get Live Data
216.50    6.50 (3.10%)
Bid:
215.00
Ask:
216.00
Spread: 1.00 (0.465%)
Market Cap: £496.37m
GBG Live PriceLast checked at - London Stock Exchange

Intraday Gb Group Share Chart

Pre-Close Trading Statement

22 Apr 2021 07:00

RNS Number : 2276W
GB Group PLC
22 April 2021
 

 

Embargoed until 7.00 a.m.

22 April 2021

 

GB GROUP PLC

("GBG" or the "Company")

 

Pre-Close Trading Statement

 

GBG (AIM: GBG), the identity data intelligence specialist, provides an update on its trading performance for the year to 31 March 2021, in advance of the release of its final results in June 2021.

 

2021

2020

Total

Growth

Organic3

Revenue

Growth (CCY)4

Total revenue 1

£217m

£199m

9%

9%

 

Adjusted operating profit 1&2

 

£58m

£48m

21%

-

Net cash/(debt)

 

£21m

(£35m)

-

-

 

 

 

 

 

 

· Total revenue and organic constant currency revenue for the year grew by 9% to £217 million, ahead of updated market consensus.1 In the full year announcement we will disclose organic revenue reflecting the impact of the two small businesses we disposed of in the last quarter of the financial year.

 

· GBG has had a strong year in challenging conditions and benefited from customers shifting to digital models. Growth was strongest in Identity, helped by US stimulus and good growth in fintech. The Location business also grew well, supported by increased transactions in the online retail sector. This growth has more than compensated for decline in those sectors affected by Covid and lower sales of Fraud products, which are traditionally deployed onsite where pandemic restrictions have impacted new sales and implementations.

 

· GBG expects to report adjusted operating profit2 of approximately £58 million, a 21% increase on last year and also ahead of updated market consensus.1 The growth rate in adjusted operating profit is underpinned by a combination of factors including business mix; the one off impact of deferring expenditure made as a prudent step in the early stages of the pandemic; lower people costs flowing from these decisions; and cost savings as a direct result of the pandemic.

 

· Net cash balances as at 31 March 2021 were £21 million (2020: £35 million net debt). Strong cash generation enabled the full repayment of the Company's bank loans by 31 March 2021 (2020: leverage of 0.8x).

 

1 Company compiled consensus of analysts' estimates for year ending 31 March 2021: Revenue of £213.2 million and adjusted operating profit of £53.5 million.

 

2 Adjusted operating profit means profit before amortisation of acquired intangibles, share-based payments, exceptional items, interest and tax. This measure is not defined under IFRS but Management believe that this Alternative Performance Measure (APM) is a more appropriate metric to understand the underlying performance of the Group.

 

3 Organic revenue excludes revenue from acquisitions in the past 12 months.

4 "CCY" indicates figure reported on a constant currency basis. Constant currency means that non-Sterling revenue in the comparative period is translated at the same exchange rate applied to the current year non-Sterling revenue.

 

 

Chris Clark, CEO of GBG, commented:

 

"I am very pleased with the performance of the business in FY21. We made significant financial and strategic progress in the most extraordinary circumstances and my thanks go to all GBG team members whose tireless work has enabled this.

 

Although Covid-related uncertainties remain front of mind, we are encouraged by the global easing of lockdowns and the pace of vaccinations in some of our key geographies. One legacy of the pandemic will be accelerated digitalisation. GBG will play a major role in this transition and over the next year we will continue to make important strategic investments in the business, its technology and in our people to fully leverage the opportunity this presents.

 

I look forward to providing more details at the time of our Full Year Results Announcement."

 

 

- Ends -

 

For further information, please contact:

 

GBG

Chris Clark, CEO & Dave Wilson, CFO & COO

 

01244 657333

Peel Hunt LLP (Nominated Adviser and Broker)

Edward Knight, Paul Gillam & Nick Prowting

 

020 7418 8900

Tulchan

James Macey White & Matt Low

 

020 7353 4200

GBG@tulchangroup.com

 

Website

www.gbgplc.com/investors

 

 

About GBG

 

GBG offers a range of solutions that help organisations quickly validate and verify the identity and location of their customers.

 

Our market-leading technology, data and expertise help our customers improve digital access, deliver a seamless experience and establish trust, so that they can transact quickly, safely and securely with their customers online.

 

Headquartered in the UK and with over 1,000 team members across 16 countries, we work with 20,000 customers in over 70 countries. Some of the world's best-known businesses rely on GBG to provide digital services and keep the economy moving, from US e-commerce giants to Asia's biggest banks and European household brands.

 

To find out more about how we help our customers establish trust with their customers, visit www.gbgplc.com and follow us on LinkedIn and Twitter@gbgplc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAXLFAADFEFA
Date   Source Headline
8th Dec 20207:00 amRNSHalf-year Report
30th Nov 20209:37 amRNSTotal Voting Rights
30th Oct 202011:00 amRNSTotal Voting Rights
22nd Oct 20203:21 pmRNSNotification of PDMR Interests
22nd Oct 20207:00 amRNSPre-Close Trading Statement and Notice of Results
1st Oct 20203:35 pmRNSNotification of Directors’ Interests
30th Sep 20209:05 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSTotal Voting Rights
20th Aug 20207:00 amRNSInvestment in CredoLab Pte Ltd
19th Aug 20204:14 pmRNSDirectorate Change
10th Aug 202011:50 amRNSResult of AGM
10th Aug 20207:00 amRNSAGM Statement
5th Aug 20202:59 pmRNSHolding(s) in Company
31st Jul 20203:19 pmRNSTotal Voting Rights
22nd Jul 202010:26 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20207:00 amRNSBlock listing Interim Review
17th Jul 202012:17 pmRNSHolding(s) in Company
8th Jul 20205:43 pmRNSNotification of PDMR Interests
7th Jul 20203:34 pmRNSHolding(s) in Company
30th Jun 20207:00 amRNSFinal Results
5th Jun 202010:31 amRNSNotice of Results
29th May 20208:56 amRNSTotal Voting Rights
22nd Apr 20207:00 amRNSPre-Close Trading Statement and Covid-19 Update
31st Mar 20207:00 amRNSTotal Voting Rights
19th Mar 202010:05 amRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotification of Directors' Interests
16th Mar 20204:12 pmRNSHolding(s) in Company
16th Mar 20204:09 pmRNSHolding(s) in Company
10th Mar 20202:20 pmRNSHolding(s) in Company
5th Mar 202010:02 amRNSNotification of Directors’ Interests
14th Feb 202010:48 amRNSHolding(s) in Company
31st Jan 20207:00 amRNSTotal Voting Rights
20th Jan 20203:02 pmRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20197:00 amRNSTotal Voting Rights
9th Dec 201910:00 amRNSAdmission of securities to trading
5th Dec 20192:58 pmRNSHolding(s) in Company
29th Nov 20193:15 pmRNSTotal Voting Rights
29th Nov 20198:33 amRNSHolding(s) in Company
28th Nov 20191:09 pmRNSCorrection - Notification of Directors' Interests
28th Nov 201910:25 amRNSNotification of Directors' Interests
26th Nov 20197:00 amRNSHalf-year Report
19th Nov 20197:00 amRNSAppointment of Non-Executive Director
31st Oct 20197:00 amRNSTotal Voting Rights
24th Oct 20197:00 amRNSPre-Close Trading Statement
30th Sep 20197:00 amRNSTotal Voting Rights
27th Sep 20199:24 amRNSNotification of Director's Interest
23rd Sep 20194:13 pmRNSNotification of Directors' Interests
20th Sep 201910:19 amRNSNotification of Directors' Interests
30th Aug 20197:00 amRNSTotal Voting Rights
12th Aug 20193:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.